Article By:
Zacks Investment Research
Wednesday, December 27, 2017 7:51 PM EDT
The year 2017 has been quite impressive one for the biotech sector as evident from the 19.4% gain registered so far by the Nasdaq Biotechnology Index. This is surely welcome news for investors since the industry suffered a decline of 19.2% last year.